Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Submitted by
admin
on May 27, 2013 - 8:17pm
Source:
Forbes
News Tags:
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Headline:
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Do Not Allow Advertisers to Use My Personal information
